Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction Sockets

Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction Sockets: a Randomized Controlled Trial

The goal of this clinical trial is to histologically, clinically, and radiographically evaluate the healing sequelae of periodontally compromised extraction sockets grafted with Bio-Oss Collagen® at 3 and 6 months following tooth extraction in molar sites. The main question it aims to answer is:

Does healing time influence the histologic, clinical, and radiographic outcomes following socket grafting (alveolar ridge preservation) in periodontally compromised extraction sockets.

Researchers will compare a healing time of 3 months to a healing time of 6 months (conventional healing duration) to see if a shorter duration is viable for implant placement.

Participants will:

Take a cone-beam computed tomography (CBCT) scan to prepare for the surgical procedure.

Undergo tooth extraction and the extraction socket will be grafted with Bio-Oss Collagen® and a collagen membrane Bio-Gide® will be placed to stabilize the graft material.

Return at 2 weeks for suture removal and either 3- or 6-months post-extraction for implant placement.

Return at 2 weeks post-implant placement for suture removal, 3 months for prosthesis fabrication, 4 months for final prosthesis loading, and 1 year post-loading.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Shanghai, China, 201999
        • Recruiting
        • Shanghai Ninth People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years of age or older
  • ASA (American Society of Anesthesia) status I or II
  • Need for molar extraction due to periodontal disease with or without chronic endodontic involvement, complying with the presentation of periodontitis stage III/IV
  • Radiographic evidence of a bone dehiscence on at least one socket wall, where the height of the horizontal (suprabony) component of the defect (alveolar bone crest - cement-enamel junction) is >50% of the corresponding root length as measured on CBCT scans prior to extraction (Ben Amara et al., 2021)
  • Radiographic evidence of at least 3 mm of residual bone wall height
  • Presence of at least one adjacent tooth to the extraction site
  • Treatment plan must include tooth replacement with an implant-supported fixed dental prosthesis

Exclusion Criteria:

  • Extraction of multiple adjacent teeth
  • Acute infection associated with the tooth to be extracted or with adjacent teeth
  • Current smokers (>10 cigarettes per day)
  • Uncontrolled diabetes mellitus (HbA1c >7.0)
  • Any active oral or systemic acute infections
  • Currently receiving chemo- or radiotherapy or a history of radiotherapy in the head and neck area
  • Diseases or medications that may compromise normal wound healing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Implant placement 3 months after tooth extraction
Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement 3 months after tooth extraction
Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement at 2 different time intervals (3 and 6 months)
Active Comparator: Implant placement 6 months after tooth extraction
Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement 6 months after tooth extraction
Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement at 2 different time intervals (3 and 6 months)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of vital bone via histomorphometric evaluation of bone core biopsies at 3 months
Time Frame: 3 months
Percentage of vital bone
3 months
Percentage of vital bone via histomorphometric evaluation of bone core biopsies at 6 months
Time Frame: 6 months
Percentage of vital bone
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported outcomes (pain) 2 weeks following tooth extraction, using a Visual Analog Score for pain (0-100)
Time Frame: 2 weeks following tooth extraction and alveolar ridge preservation
Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").
2 weeks following tooth extraction and alveolar ridge preservation
Linear dimensional alterations of the alveolar ridge from the time of tooth extraction to the time of implant placement (3 months)
Time Frame: 3 months
Clinical and radiographic (via CBCT) assessment. The buccal-lingual ridge width at the time of the extraction will be measured clinically using a periodontal probe (UNC-15) and prior to implant placement (3-months). The same measurements will be performed radiographically through the CBCTs taken prior to tooth extraction and prior to implant placement, utilizing a CBCT viewer software. The linear vertical alterations will be used utilizing the same methods, using fiduciary anatomical landmarks. Superimposition of the digital files obtained from the intra-oral scanner will be utilized to verify these changes clinically.
3 months
Linear dimensional alterations of the alveolar ridge from the time of tooth extraction to the time of implant placement (6 months)
Time Frame: 6 months
Clinical and radiographic (via CBCT) assessment. The buccal-lingual ridge width at the time of the extraction will be measured clinically using a periodontal probe (UNC-15) and prior to implant placement (6-months). The same measurements will be performed radiographically through the CBCTs taken prior to tooth extraction and prior to implant placement, utilizing a CBCT viewer software. The linear vertical alterations will be used utilizing the same methods, using fiduciary anatomical landmarks. Superimposition of the digital files obtained from the intra-oral scanner will be utilized to verify these changes clinically.
6 months
Assessment of the mucosal healing of the extraction sites at 2 weeks using a wound healing index (1-3 scale rating)
Time Frame: 2 weeks following tooth extraction and alveolar ridge preservation
Wound Healing Index.1-3 scale rating: 1) Uneventful Healing, 2) Normal healing with moderate soft tissue inflammation, erythema but no suppuration and 3) poor wound healing with significant signs of clinical inflammation and/or suppuration
2 weeks following tooth extraction and alveolar ridge preservation
Assessment of the mucosal healing after implant placement at 2 weeks using a wound healing index (1-3 scale rating)
Time Frame: 2 weeks after dental implant placement
Wound Healing Index.1-3 scale rating: 1) Uneventful Healing, 2) Normal healing with moderate soft tissue inflammation, erythema but no suppuration and 3) poor wound healing with significant signs of clinical inflammation and/or suppuration
2 weeks after dental implant placement
Patient reported outcomes (number of days of total or partially impaired activity) following tooth extraction
Time Frame: At the time of implant placement (3 or 6 months)
Number of days of total or partially impaired activity
At the time of implant placement (3 or 6 months)
Patient reported outcomes (number of days of total or partially impaired activity) following implant placement
Time Frame: 4 months post implant placement
Number of days of total or partially impaired activity
4 months post implant placement
Patient reported outcomes (pain) 3 months following tooth extraction, using a Visual Analog Score for pain (0-100)
Time Frame: 3 months following tooth extraction and alveolar ridge preservation
Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").
3 months following tooth extraction and alveolar ridge preservation
Patient reported outcomes (pain) 6 months following tooth extraction, using a Visual Analog Score for pain (0-100)
Time Frame: 6 months following tooth extraction and alveolar ridge preservation
Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").
6 months following tooth extraction and alveolar ridge preservation
Patient reported outcomes (patient satisfaction), using a Visual Analog Scale (0-100)
Time Frame: Up to 30 days post implant crown delivery
Patients will be asked to rate their satisfaction in terms of function, comfort and esthetics, using a Visual Analog Scale (0-100, with 0 meaning "not at satisfied at all" and 100 corresponding to "perfectly satisfied").
Up to 30 days post implant crown delivery
Implant survival rate
Time Frame: 1 year post implant loading
Percentage of implants still in the mouth
1 year post implant loading
Marginal bone level changes
Time Frame: 1 year post implant loading
Measured in millimeters using standardized parallel technique intraoral radiographs
1 year post implant loading

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

October 21, 2024

First Submitted That Met QC Criteria

October 21, 2024

First Posted (Actual)

October 23, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 17, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SDC-2024-1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe